Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217210 · ClinicalTrials.gov registry record · NA
Multi-Ingredient Preworkout Supplement on Peak Torque and Muscle Activation During Fatigue
A NA study, sponsored by Northern Illinois University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT07217210: Completed NA study, sponsored by Northern Illinois University.
NCT07217210 is a NA study that has completed, run by Northern Illinois University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217210, a NA study, has completed, sponsored by Northern Illinois University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The primary purpose of the present study was to examine the acute effects of a MIPS product on peak torque production of the leg extensors during a fatiguing isokinetic protocol involving isometric, concentric, and eccentric muscle actions. In addition, we investigated the effects of the MIPS supplement on EMG amplitude and median power frequency (MDF) responses from the vastus lateralis, rectus femoris, and vastus medi-alis muscles.
Primary Outcome
Isometric, concentric, and eccentric.
Interventions
- DIETARY_SUPPLEMENT Multi-ingredient preworkout supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
What the finished NCT07217210 record still lists
NCT07217210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Multi-ingredient preworkout supplement is the first listed.
NCT07217210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07217210 about?
NCT07217210 is a clinical study titled "Multi-Ingredient Preworkout Supplement on Peak Torque and Muscle Activation During Fatigue". The primary purpose of the present study was to examine the acute effects of a MIPS product on peak torque production of the leg extensors during a fatiguing isokinetic protocol involving isometric, concentric, and eccentric muscle actions. In addition, we investigated the effects of the MIPS supple...
What is the current status of trial NCT07217210?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2021-11-15. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT07217210?
The interventions under investigation include: Multi-ingredient preworkout supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07217210?
This trial is sponsored by Northern Illinois University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07217210's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI